🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well alisertib works in treating patients w...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2012-08-22
Trial ID
NCT01653028
Treatments Being Tested
RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2011-10
Trial ID
NCT01316692
Background: Progress in developing new effective therapies in advanced and...
Status
Completed
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2014-08-28
Trial ID
NCT02109328
Treatments Being Tested
This is an open-label, multicenter study with a phase 1 dose escalation por...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01045421
Treatments Being Tested
RATIONALE: MLN8237 may stop the growth of cancer cells by blocking some of ...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT02444884
Treatments Being Tested
The purpose of this study was to determine the safety profile, maximum tole...
Status
Completed
Location
National Cancer Centre
Start Date
2012-02-06
Trial ID
NCT01512758
Treatments Being Tested
This phase I trial studies the side effects and best dose of alisertib when...
Status
Completed
Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Start Date
2015-01-30
Trial ID
NCT02186509
This is an open-label, multicenter, phase 2 study of alisertib (MLN8237) in...
Status
Completed
Location
Hematology and Oncology Associates of Northern New Jersey
Start Date
2009-02-10
Trial ID
NCT00830518
Treatments Being Tested
The purpose of this study is to assess the drug-drug interaction (DDI) of e...
Status
Completed
Location
Multiple Locations
Start Date
2013-06-25
Trial ID
NCT01844583
Treatments Being Tested
Objectives: Objectives The primary objective of this study is to: To ass...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-05-20
Trial ID
NCT02293005
Treatments Being Tested